Related Experiment Video
Updated: Mar 15, 2026

Induction of Drug-Induced, Autoimmune Hepatitis in BALB/c Mice for the Study of Its Pathogenic Mechanisms
Published on: May 29, 2020
Mincle Signaling Promotes Con A Hepatitis
Stephanie H Greco1, Alejandro Torres-Hernandez1, Aleksandr Kalabin1
1S. Arthur Localio Laboratory, Department of Surgery, New York University School of Medicine, New York, NY 10016;
Abstract:
Con A hepatitis is regarded as a T cell-mediated model of acute liver injury. Mincle is a C-type lectin receptor that is critical in the immune response to mycobacteria and fungi but does not have a well-defined role in preclinical models of non-pathogen-mediated inflammation. Because Mincle can ligate the cell death ligand SAP130, we postulated that Mincle signaling drives intrahepatic inflammation and liver injury in Con A hepatitis. Acute liver injury was assessed in the murine Con A hepatitis model using C57BL/6, Mincle(-/-), and Dectin-1(-/-) mice. The role of C/EBPβ and hypoxia-inducible factor-1α (HIF-1α) signaling was assessed using selective inhibitors. We found that Mincle was highly expressed in hepatic innate inflammatory cells and endothelial cells in both mice and humans. Furthermore, sterile Mincle ligands and Mincle signaling intermediates were increased in the murine liver in Con A hepatitis. Most significantly, Mincle deletion or blockade protected against Con A hepatitis, whereas Mincle ligation exacerbated disease. Bone marrow chimeric and adoptive transfer experiments suggested that Mincle signaling in infiltrating myeloid cells dictates disease phenotype. Conversely, signaling via other C-type lectin receptors did not alter disease course. Mechanistically, we found that Mincle blockade decreased the NF-κβ-related signaling intermediates C/EBPβ and HIF-1α, both of which are necessary in macrophage-mediated inflammatory responses. Accordingly, Mincle deletion lowered production of nitrites in Con A hepatitis and inhibition of both C/EBPβ and HIF-1α reduced the severity of liver disease. Our work implicates a novel innate immune driver of Con A hepatitis and, more broadly, suggests a potential role for Mincle in diseases governed by sterile inflammation.
Insights
This study reveals Mincle (Macrophage-inducible C-type lectin) drives T cell-mediated liver injury in Con A hepatitis. Blocking Mincle protects against this sterile inflammation, highlighting its potential therapeutic role.
Area of Science:
- Immunology
- Hepatology
- Inflammation Research
Background:
- Concanavalin A (Con A) hepatitis serves as a T cell-mediated acute liver injury model.
- The C-type lectin receptor Mincle's role in non-pathogen-mediated inflammation is unclear.
- Mincle's interaction with SAP130 suggests a potential role in Con A hepatitis.
Purpose of the Study:
- To investigate the role of Mincle signaling in Con A hepatitis.
- To determine if Mincle blockade can ameliorate liver injury.
- To elucidate the downstream signaling pathways involved.
Main Methods:
- Utilized a murine Con A hepatitis model with wild-type, Mincle(-/-), and Dectin-1(-/-) mice.
- Assessed liver injury and inflammatory cell infiltration.
- Employed selective inhibitors for C/EBPβ and hypoxia-inducible factor-1α (HIF-1α) signaling.
- Conducted bone marrow chimeric and adoptive transfer experiments.
Main Results:
- Mincle expression was elevated in hepatic inflammatory cells and endothelial cells in mice and humans.
- Mincle deletion or blockade significantly protected against Con A-induced liver injury.
- Mincle signaling in myeloid cells was critical for disease pathogenesis.
- Mincle blockade reduced C/EBPβ and HIF-1α signaling, lowering nitrite production.
Conclusions:
- Mincle acts as a key innate immune driver in Con A hepatitis.
- Targeting Mincle signaling offers a potential therapeutic strategy for sterile inflammatory liver diseases.
- This study expands the understanding of Mincle's function beyond pathogen recognition.

